Miłosz Wilczyński

11PUBLICATIONS
11CO-AUTHORS
Cancer geneticsMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 26, 2024
High-Grade Serous Ovarian Cancer-A Risk Factor Puzzle and Screening Fugitive.

Jacek Wilczyński, Edyta Paradowska, Miłosz Wilczyński

|Jan 23, 2024
Differential microRNA Expression Analysis in Patients with HPV-Infected Ovarian Neoplasms.

Dariusz Jarych, Damian Mikulski, Miłosz Wilczyński

|Jan 22, 2024
Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer-The Possibility or the Necessity?

Jacek Wilczyński, Edyta Paradowska, Miłosz Wilczyński

|Oct 14, 2022
The Toll-like Receptor 4 Polymorphism Asp299Gly Is Associated with an Increased Risk of Ovarian Cancer.

Katarzyna D Kania, Daria Haręża, Jacek R Wilczyński

|Mar 10, 2022
Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies.

Jacek R Wilczyński, Miłosz Wilczyński, Edyta Paradowska

|Feb 08, 2021
A body shape index (ABSI) and endometrial pathology.

Miłosz Wilczyński, Daria Domańska-Senderowska, Shiar Agata Kassassir-Ćwiklak

Pageof 2